Compare iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ Inv Grade Corporate Bond ETF vs RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) — how do they compare? iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $103.4 (market cap $29.07B), while RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) trades at $37.8 (market cap $63.57B). The key difference: RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) is far larger — about 2.2× iShares iBoxx $ Inv Grade Corporate Bond ETF's market cap, and RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) pays a 2.49% dividend while iShares iBoxx $ Inv Grade Corporate Bond ETF pays none. Which is the better fit depends on your goals.
| LQD | RELX | |
|---|---|---|
Market Cap | $29.07B | $63.57B |
Volume | 26,122,352 | 1,602,093 |
Sector | Fixed Income | Industrials |
52-Week High | $112.91 | $46.80 |
52-Week Low | $101.83 | $27.73 |
Typical Hold Time | 126 Days | — |
Enterprise Value | — | $75.05B |
Dividend Yield | — | 2.49% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LQD trades at $102.55, down slightly by 0.03% on the day, with technical indicators signaling a bearish trend as selling pressure outweighs buying. The ETF faces headwinds from rising bond yields and increased short interest, which grew 53.1% in September. Recent dividends of $0.44-$0.46 provide income support, but the overall market sentiment remains cautious amid a challenging fixed-income environment.
The outlook for LQD is constrained by persistent bond market volatility and higher interest rates, which pressure corporate bond valuations. While the ETF's investment-grade portfolio offers relative safety, further yield increases could limit upside. Key risks include Fed policy uncertainty and economic slowdown concerns, warranting a neutral to cautious stance for equity-focused investors.
RELX trades at $36.70, up 0.44% with neutral technical signals. The company demonstrates strong profitability with 23.27% net margins and 132.36% ROE, though valuation metrics appear elevated with P/E of 22.21 and P/B of 38.89. Recent earnings show mixed results with Q2 2026 beating expectations while Q4 2025 missed. Analyst sentiment remains positive with 71% buy ratings and consensus price target of $26.00.
The investment case balances strong fundamentals against premium valuation. Growth catalysts include AI-driven product adoption and margin expansion, while risks involve competitive pressures and valuation concerns. With solid cash flow generation and institutional support, RELX offers quality exposure but requires monitoring of valuation multiples and competitive dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →About RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share)
RELX PLC is a UK-based information and analytics company operating across four segments: Risk (fraud prevention and compliance analytics via LexisNexis Risk Solutions), Scientific, Technical & Medical (Elsevier's research and clinical content), Legal (LexisNexis Legal & Professional's research tools), and Exhibitions (RX's trade events). It serves professional, business, and government customers worldwide.
Read more on RELX →
